Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-F in Haplo-identical Stem Cell Transplantation
NCT00616954Phase 3Terminated
- Sponsor
- Hadassah Medical Organization
- Start
- May 2008
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Hadassah Medical Organization. Started May 2008; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00616954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616954.